Interview: Woundchek Laboratories

The cost of ineffective wound treatment range into billions. Point of care wound diagnostic devices can reduce the cost of ineffective treatment and delayed healing. The UK company Woundchek Laboratories therefore has developed the first point of care test to detect elevated protease activity (EPA).

Source: MEDICA.de